Quoin Pharmaceuticals Ltd ADR (NASDAQ:QNRX) has a beta value of 1.94 and has seen 11.73 million shares traded in the recent trading session. The company, currently valued at $3.06M, closed the recent trade at $0.77 per share which meant it gained $0.27 on the day or 52.76% during that session. The QNRX stock price is -702.6% off its 52-week high price of $6.18 and 37.66% above the 52-week low of $0.48. If we look at the company’s 10-day average daily trading volume, we find that it stood at 56420.0 shares traded. The 3-month trading volume is 482.05K shares.
The consensus among analysts is that Quoin Pharmaceuticals Ltd ADR (QNRX) is Buy stock at the moment, with a recommendation rating of 1.00. 0 analysts rate the stock as a Sell, while 0 rate it as Overweight. 0 out of 1 have rated it as a Hold, with 1 advising it as a Buy. 0 have rated the stock as Underweight. The expected earnings per share for the stock is -0.49.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Quoin Pharmaceuticals Ltd ADR (NASDAQ:QNRX) trade information
Sporting 52.76% in the green today, the stock has traded in the green over the last five days, with the highest price hit on recent trading when the QNRX stock price touched $0.77 or saw a fall of -11.59%. Year-to-date, Quoin Pharmaceuticals Ltd ADR shares have moved -84.30%, while the 5-day performance has seen it change 53.67%. Over the past 30 days, the shares of Quoin Pharmaceuticals Ltd ADR (NASDAQ:QNRX) have changed 37.14%. Short interest in the company has seen 15195.0 shares shorted with days to cover at 0.01.
Quoin Pharmaceuticals Ltd ADR (QNRX) estimates and forecasts
Figures show that Quoin Pharmaceuticals Ltd ADR shares have outperformed across the wider relevant industry. The company’s shares have gained 5.02% over the past 6 months, with this year growth rate of 79.05%, compared to 17.60% for the industry.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was 67.35% over the past 5 years.
QNRX Dividends
Quoin Pharmaceuticals Ltd ADR is expected to release its next earnings report on 2024-Nov-06 this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
Quoin Pharmaceuticals Ltd ADR (NASDAQ:QNRX)’s Major holders
Insiders own 2.39% of the company shares, while shares held by institutions stand at 7.10% with a share float percentage of 7.27%. Investors are also buoyed by the number of investors in a company, with Quoin Pharmaceuticals Ltd ADR having a total of 11.0 institutions that hold shares in the company.
